General form of registration statement for all companies including face-amount certificate companies

SCHEDULE OF REVENUE RECOGNITION (Details) (Parenthetical)

v3.24.3
SCHEDULE OF REVENUE RECOGNITION (Details) (Parenthetical) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Product Information [Line Items]            
Revenue from Contract with Customer, Excluding Assessed Tax $ 2,350,386 $ 298,484 $ 7,154,429 $ 319,143 $ 2,532,499 $ 4,803
Health Care, Patient Service [Member]            
Product Information [Line Items]            
Revenue from Contract with Customer, Excluding Assessed Tax     6,259,806 [1] $ 248,654 [1] $ 2,199,558 [2] [2]
Health Care, Patient Service [Member] | CyPath® Lung [Member]            
Product Information [Line Items]            
Revenue from Contract with Customer, Excluding Assessed Tax     $ 332,000      
[1] Patient services fees include direct billing for CyPath® Lung diagnostic test of approximately $332,000 and $24,000 for the nine months ended September 30, 2024 and 2023.
[2] Patient services fees includes direct billing for CyPath® Lung diagnostic test.